DermTech, Inc. announced that Dr. John Dobak expects to step away from his role as president and director under a planned transition. Dr. John Dobak will continue to serve as president and director until the earlier of the date the Board appoints a successor and September 30, 2023. The Board has initiated a comprehensive search to identify Dr. Dobak's replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1179 USD | -18.97% |
|
-62.81% | -93.26% |
06-18 | Sector Update: Health Care Stocks Edge Up Late Afternoon | MT |
06-18 | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.26% | 4.12M | |
-10.93% | 11.34B | |
-11.84% | 7.46B | |
+31.42% | 5.65B | |
+4.38% | 5.56B | |
-17.33% | 3.77B | |
+7.01% | 2.57B | |
-64.33% | 2.39B | |
-10.17% | 2.26B | |
+24.35% | 2.15B |
- Stock Market
- Equities
- DMTK Stock
- News DermTech, Inc.
- DermTech, Inc. Announces John Dobak Expects to Step Away as President and Director